Sana Biotechnology files to go public, looks to cure disease by modifying genes in the body
GeekWire
JANUARY 13, 2021
Less than three years after it was founded and with no revenue on the books, Sana Biotechnology has f iled to go public. And like many biotechnology companies it is losing money. Sana would become the latest in a string of Seattle area biotechnology companies to join the public ranks in recent months.
Let's personalize your content